IDXX

IDEXX Laboratories Inc.

Price

$506.67

return (12m)

-19.23%

p/e

36.04

p/bv

25.47

DIVIDEND YIELD

0.00%

IDXX price

IDEXX Laboratories

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IDXX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.61%

3 months

-10.78%

1 year

-19.23%

2 years

7.25%

5 years

-17.31%

10 years

332.90%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals IDXX

Valuation

P/E

36.04

Sector 1.08

Industry 3.46

P/BV

25.47

Sector 1.86

Industry 2.13

P/Revenue (PSR)

9.02

Sector 1.54

Industry 1.72

EV/EBITDA

87.89

Sector -46.43

Industry 1.72

EV/EBIT

96.33

Sector -49.92

Industry -4.29

P/EBITDA

25.41

Sector -31.92

Industry -53.68

P/EBIT

28.09

Sector -43.90

Industry -50.97

P/Total Assets

11.93

Sector 0.85

Industry 0.96

P/Net Current Assets

-128.23

Sector -25.98

Industry -11.19

P/Working Capital

185.14

Sector -3.94

Industry 2.92

EPS

14.43

Sector -0.70

Industry -0.60

BVPS

20.42

Sector 4.54

Industry 4.74

Efficiency

Gross Margin

62.45%

Sector 49.38%

Industry 50.68%

EBITDA Margin

38.51%

Sector -280.65%

Industry -57.47%

EBIT Margin

35.13%

Sector -163.23%

Industry -56.25%

Operating Margin

32.03%

Sector -19.46%

Industry -25.80%

Net Profit Margins

25.03%

Sector -23.67%

Industry -29.17%

Asset Turnover

0.35

Sector 0.13

Industry 0.15

Profitability

ROE

70.67%

Sector -23.63%

Industry -22.30%

ROA

33.11%

Sector -24.09%

Industry -24.15%

ROIC

48.73%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.17

Sector 1.90

Industry 1.98

Net Debt / EBITDA

0.22

Sector -23.21

Industry -2.21

Net Debt / EBIT

0.24

Sector -11.18

Industry -1.50

Net Debt / Equity

0.06

Sector -0.63

Industry -0.29

Gross Debt / Equity

0.19

Sector -0.72

Industry -0.82

Equity/Assets

0.47

Sector 0.46

Industry 0.47

Liabilities/Assets

0.53

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

7.21%

Sector -

Industry -

5Y Earnings CAGR

8.88%

Sector -

Industry -

Fundamentals IDXX

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF IDEXX Laboratories ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$506.67

Fair Value

$81.42

Upside

-83.93%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IDXX IDEXX Laboratories Inc.	$506.67	-19.29%	0.00%	36.04	25.47	70.67%	25.03%
ABT Abbott Laboratories	$98.66	-23.65%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$85.51	-9.58%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.34	-56.22%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$81.07	-28.84%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$225.98	-18.84%	1.12%	20.92	4.84	23.13%	26.94%
COHR Coherent Inc.	$334.56	191.50%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$275.40	-23.80%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.09	-10.70%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.01	-8.01%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$180.16	-3.83%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$84.77	27.74%	0.00%	32.65	12.45	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.78	12.04%	0.00%	48.96	4.59	9.37%	15.43%
ALGN Align Technology Inc.	$140.75	7.03%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$26.88	-22.52%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$85.47	20.47%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$88.49	-9.28%	1.10%	20.85	1.33	6.39%	9.48%
HSIC Henry Schein Inc.	$83.66	26.68%	0.00%	23.66	2.50	10.56%	2.96%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IDXX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT IDEXX Laboratories

IDEXX Laboratories Inc.

Average Investor10 user rating

5.0 (35 people)

United States

43 years

Founded: 1983

1991

Time since IPO - 35 years

10.350

Employees

IDEXX Laboratories Inc. (United States) is listed on the Nasdaq and has a market capitalization of $41.07 billion, with shareholders equity totaling $1.61 billion.

The company employs approximately 10.350 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, IDEXX Laboratories Inc. reported $4.55 billion in revenue, generating net income of $1.14 billion.

Key financial metrics include a P/E ratio of 36.04, a price-to-book (P/B) ratio of 25.47, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IDXX.

Market cap

$41.07 billion

Net worth

$1.61 billion

$1,612,575,000.00

Assets

$3.44 billion

$3,442,335,000.00

Total Shares Outstanding

78.95 million

78,954,000

Average Daily Trading Volume

$543.08 Thousand

$543,076.96

Sector

Health

Industry

Medical Supplies and Equipment

IDXX

revenue by Business Segment IDEXX Laboratories

Revenue by Region IDEXX Laboratories

IDXX revenue and profits

Financial Results IDXX

DRAG THE FRAME TO SEE MORE DATA

IDXX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.95 18,85% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$278.51 --7,16% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$64.99 69,02% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$396.51 35,25% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$40.20 --14,37% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$258.45 39,34% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,188.72 41,45% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$439.17 3,52% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45